Inside informationEnglish
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 19/06/2026, 12:31
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118646_20260619